Indoor Allergens: Identifying Environmental Triggers and Supporting Effective Management 

Introduction

Indoor allergens are those substances present within the built environment which can trigger an allergic response in sensitised individuals. Common sources include house dust mites, pet and mould allergens. For healthcare professionals, recognising these exposures is important because they may contribute to persistent or poorly controlled respiratory and allergic symptoms.

Indoor allergen exposure can play a role in conditions including allergic rhinitis, asthma and eczema. Symptoms may be influenced by the type, level and duration of exposure, as well as an individual’s degree of sensitisation. Importantly, relevant exposures are not confined to the home; patients may also encounter allergens in workplaces, schools and other indoor environments where prolonged times are spent.

A detailed allergy-focused history should identify where and when symptoms occur, alongside possible environmental triggers. This article reviews the principal indoor allergens, approaches to clinical assessment and practical strategies for reducing relevant exposure.

This is particularly relevant in asthma, as up to 90% of childhood asthma cases are estimated to be allergic in origin, highlighting the importance of environmental allergens as potential triggers in susceptible individuals. Cummings 2024 1. 

Key indoor allergen sources

Indoor allergens originate from a variety of biological sources, with house dust mites, pets and moulds being among the most clinically significant.

House dust mites are microscopic organisms commonly found in bedding, mattresses, carpets and upholstered furnishings, where they feed on shed human skin. They thrive in warm, humid conditions, making bedrooms an important site of exposure. House dust mite allergens are easily disturbed and inhaled and sensitisation is associated with allergic rhinitis and asthma. Exposure can vary considerably between indoor environments and seasons, depending on factors such as humidity, ventilation, and indoor temperature.

Pets, particularly cats and dogs, are another important source of indoor allergens. These allergens are commonly thought to be from animal hair. However, they are found in skin flakes (dander), saliva, and urine and can become widely distributed through household dust and clothing and footwear. Cat allergens in particular can persist in indoor environments even after the animal has left the premises. For sensitised individuals, exposure may therefore occur outside the home, including schools, workplaces and other buildings where allergens have been transferred.

Moulds can grow in damp indoor environments, particularly where there is persistent moisture, inadequate ventilation, or water damage. Fungal spores and other components may act as allergens and can contribute to respiratory symptoms in sensitised individuals. However, it is important to distinguish an IgE-mediated allergic response from the broader respiratory and health effects associated with exposure to damp or mould-affected environments. Consequently, identification and remediation of the underlying dampness should form an important part of managing relevant exposure.

Clinical assessment: Identifying a possible indoor trigger

Assessment should incorporate a structured environmental history alongside the standard allergy-focused history. Establishing whether symptoms occur predominantly indoors, at home or at work – and whether they improve when the patient spends time outdoors or away from a particular environment – can help support a diagnosis.

Questions should include the sleep environment, including bedding, mattresses, carpets and upholstered furnishings eg, fabric bed heads and cushions as well as exposure to cats, dogs or other animals. The history should also explore occupational exposures and signs of dampness, visible mould or condensation. Housing conditions, ventilation and recent building or water damage may provide additional sources of evidence to support a diagnosis.

Importantly, although symptoms may occur after exposure, a temporal association alone is insufficient to demonstrate that exposure is the cause of the symptoms.

Clinicians should consider patterns of exposure, symptom onset and resolution, and whether these are consistent with the suspected trigger. Where the history suggests an allergic mechanism, skin-prick testing or specific IgE testing may help identify sensitisation to suspected allergens. Results should be interpreted alongside the clinical history, as sensitisation does not necessarily indicate that an allergen is causing the patient’s symptoms.

Management and exposure reduction

Management should focus on individualised exposure reduction, targeting allergens that are clinically relevant rather than recommending broad or indiscriminate environmental measures. The approach should reflect the patient’s sensitisation profile, symptoms, living circumstances, and ability to modify their environment.

For house dust mites, measures may include regular laundering of bedding at high temperatures>60 degrees, using appropriate mattress and pillow coverings, reducing indoor humidity and maintaining effective cleaning routines. The likely benefit of individual interventions should be considered in the context of the patient’s overall clinical picture rather than assuming that any single measure will eliminate exposure.

For pet allergens, management should be tailored to the individual and their circumstances. Keeping pets out of bedrooms and off soft furnishings like sofas. Regularly vacuuming with a Hepa filter hoover. Where avoidance is not practical or appropriate, clinicians can discuss strategies to reduce exposure while ensuring that treatment of the underlying allergic condition is optimised.

Where mould is identified, addressing the underlying cause of dampness is central. This may involve improving ventilation, repairing leaks or resolving condensation and water damage. Cleaning visible mould alone is unlikely to provide a lasting solution if the moisture source remains.

Environmental interventions should complement, rather than automatically replace, evidence-based pharmacological treatment for conditions such as allergic rhinitis and asthma. (NICE 2024)2. 

Shared decision-making is particularly important where patients have limited control over housing conditions, including those in rented accommodation or poorly maintained homes. Practical, achievable recommendations are more likely to support sustained exposure reduction. More information including practical tips on allergen reduction can be found in the Allergy UK Factsheet. Allergy UK (2024) Your quick guide to: Indoor Air Quality. 3 

Beyond the Clinic: Uncovering Hidden Allergens in the Home

What we see and hear from patients and their families in clinic may tell only part of the story. Indoor allergens and environmental factors can be difficult to identify without understanding a patient’s home environment, where issues such as damp, pets, bedding or sleeping arrangements may be contributing to ongoing symptoms. Community nursing teams can provide an important bridge between clinic and home, helping to identify potential triggers, reinforce treatment plans and support families to make realistic changes to reduce exposure.

When should healthcare professionals investigate further?

Further assessment may be warranted where allergic rhinitis, asthma, or eczema remains persistent or poorly controlled despite appropriate management, particularly when symptoms show a consistent and reproducible relationship with a specific indoor environment. (Scadding et al 2017). 4 

Investigation should also be considered where there is suspected occupational or housing-related exposure, or recurrent respiratory symptoms associated with damp or mould-affected accommodation.

Depending on the clinical presentation, referral to an allergy, respiratory or other relevant specialist service may be appropriate to clarify diagnosis, assess sensitisation and guide management. However, clinicians should avoid attributing symptoms to indoor allergens without supporting evidence. Where the history or investigation does not indicate an allergic mechanism, alternative diagnoses and other environmental or respiratory causes should be considered. (BSACI 2024).  5 

Key takeaway messages

• Indoor allergens can contribute to the development or exacerbation of allergic rhinitis, asthma, and eczema in sensitised individuals.
• A detailed environmental history can help identify relevant exposures and symptom patterns, providing important context for the assessment of suspected allergic disease
• Management should focus on plausible, clinically relevant triggers identified through the clinical history and appropriate investigation, rather than adopting blanket avoidance measures in the absence of supporting evidence
• Exposure reduction strategies should complement, rather than replace, appropriate pharmacological and clinical management of allergic disease.